DataMeds AI, Inc. - Common Stock (MEDS)
Investment Snapshot
- Piotroski F-Score 3/9 — signs of financial weakness
- Negative net margin (-474.4%) — currently unprofitable
- Revenue growing at 29% annually
DataMeds AI, Inc. - Common Stock (MEDS) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $10 million . Key value metrics: Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
DataMeds AI, Inc. - Common Stock — Fundamental Analysis Summary
StockPik's composite Value Score for MEDS is 38/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MEDS reports a thin gross margin of 7.7% and a negative operating margin of -356.4%.
MEDS shows revenue growing at 29% year-over-year, with earnings declining at 1,377%.